$AIMD
Ainos, Inc.

2018 Q1 Form 10-Q Financial Statement

#000101476318000010 Filed on May 23, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q1
Revenue $56.59K $0.00
YoY Change
Cost Of Revenue $43.34K $0.00
YoY Change
Gross Profit $13.25K $0.00
YoY Change
Gross Profit Margin 23.42%
Selling, General & Admin $199.3K $180.0K $185.0K
YoY Change 7.73% -21.74% 52.55%
% of Gross Profit 1504.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $199.3K $180.0K $185.0K
YoY Change 7.73% -21.74% 52.55%
Operating Profit -$186.1K -$180.0K -$185.0K
YoY Change 0.56% -21.74% 52.55%
Interest Expense $1.380K -$30.00K $3.959K
YoY Change -65.14% 993.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$190.0K -$210.0K -$190.0K
YoY Change 0.0% -8.7% 58.33%
Income Tax
% Of Pretax Income
Net Earnings -$187.4K -$210.0K -$189.0K
YoY Change -0.81% -8.7% 55.35%
Net Earnings / Revenue -331.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.08 -$0.14 -$0.13
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.710M $1.980M $50.00K
YoY Change 3320.0% 1423.08% -80.77%
Cash & Equivalents $1.707M $2.038M $52.97K
Short-Term Investments
Other Short-Term Assets $10.00K $80.00K $100.0K
YoY Change -90.0% -27.27%
Inventory $22.67K
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $1.719M $2.084M $152.3K
YoY Change 1029.17% 694.38% -43.6%
LONG-TERM ASSETS
Property, Plant & Equipment $22.69K $27.00K $39.91K
YoY Change -43.14% -38.94% 299.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $201.0K $209.4K $195.9K
YoY Change 2.59% 4.55% 144.84%
TOTAL ASSETS
Total Short-Term Assets $1.719M $2.084M $152.3K
Total Long-Term Assets $201.0K $209.4K $195.9K
Total Assets $1.920M $2.294M $348.1K
YoY Change 451.6% 395.78% -0.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0K $160.0K $140.0K
YoY Change 0.0% -5.88% -17.65%
Accrued Expenses $10.00K
YoY Change
Deferred Revenue $7.491K
YoY Change
Short-Term Debt $690.0K $890.0K $790.0K
YoY Change -12.66% 12.66% 49.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.140M $1.823M $1.254M
YoY Change -9.06% 43.26% 81.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.140M $1.823M $1.254M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.140M $1.823M $1.254M
YoY Change -9.06% 43.26% 81.72%
SHAREHOLDERS EQUITY
Retained Earnings -$2.153M -$1.884M -$1.456M
YoY Change 47.89% 48.74%
Common Stock $337.2K $231.6K $223.5K
YoY Change 50.89% 5.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $698.9K $470.8K -$905.7K
YoY Change
Total Liabilities & Shareholders Equity $1.920M $2.294M $348.1K
YoY Change 451.6% 395.78% -0.53%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q1
OPERATING ACTIVITIES
Net Income -$187.4K -$210.0K -$189.0K
YoY Change -0.81% -8.7% 55.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$76.52K -$350.0K -$126.5K
YoY Change -39.51% 288.89% -7707.46%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $10.00K
YoY Change -80.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.687K -$10.00K -$5.267K
YoY Change -67.97% -80.0% -38.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -195.0K 2.200M 50.63K
YoY Change -485.19% 2100.0% -79.75%
NET CHANGE
Cash From Operating Activities -76.52K -350.0K -126.5K
Cash From Investing Activities -1.687K -10.00K -5.267K
Cash From Financing Activities -195.0K 2.200M 50.63K
Net Change In Cash -273.2K 1.840M -81.15K
YoY Change 236.66% -4700.0% -133.39%
FREE CASH FLOW
Cash From Operating Activities -$76.52K -$350.0K -$126.5K
Capital Expenditures $10.00K $10.00K
Free Cash Flow -$76.52K -$360.0K -$136.5K
YoY Change -43.94% 157.14% 1537.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 amar Amount Of Private Placement
AmountOfPrivatePlacement
937500
CY2016Q3 amar Amount Of Private Placement
AmountOfPrivatePlacement
1875000
CY2017Q4 amar Amount Of Private Placement
AmountOfPrivatePlacement
2812500
CY2018Q1 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
39784798
CY2017Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
886481
CY2018Q1 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
691481
CY2016Q1 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
5000000
CY2016Q3 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
10000000
CY2017Q4 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
15000000
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
139492
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
159300
CY2018Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
2248
CY2017Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2514263
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2123205
CY2018Q1 us-gaap Assets
Assets
1920330
CY2017Q4 us-gaap Assets
Assets
2293834
CY2018Q1 us-gaap Assets Current
AssetsCurrent
1719380
CY2017Q4 us-gaap Assets Current
AssetsCurrent
2084451
CY2018Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 36pt; vertical-align: top;"> <div style=" text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div> </td> <td style="vertical-align: top;"> <div style=" text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div> The accompanying financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 17, 2018, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018.</div></div> </td> </tr> </table></div>
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1706804
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1980015
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52971
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-273211
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-81154
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33724261
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23156563
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33724261
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23156563
CY2018Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
3777306
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
337243
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
231565
CY2018Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7491
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
43339
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
CY2018Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
58135
CY2018Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
301773
CY2017Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
777258
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
178257
CY2017Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
182386
CY2018Q1 us-gaap Gross Profit
GrossProfit
13251
CY2017Q1 us-gaap Gross Profit
GrossProfit
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018Q1 us-gaap Interest Expense
InterestExpense
1380
CY2017Q1 us-gaap Interest Expense
InterestExpense
3959
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
3819
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2018Q1 us-gaap Inventory Net
InventoryNet
CY2017Q4 us-gaap Inventory Net
InventoryNet
22666
CY2018Q1 us-gaap Liabilities
Liabilities
1140237
CY2017Q4 us-gaap Liabilities
Liabilities
1823039
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1920330
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2293834
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1140237
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1823039
CY2018Q1 us-gaap Minority Interest
MinorityInterest
81166
CY2017Q4 us-gaap Minority Interest
MinorityInterest
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50625
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1687
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5267
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76524
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126512
CY2018Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4992
CY2017Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-192430
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-188972
CY2018Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2018Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
199309
CY2017Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
185013
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-186058
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-185013
CY2018Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1687
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5267
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Revenues
Revenues
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
199309
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
185013
CY2018Q1 us-gaap Stock Issued1
StockIssued1
496736
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10328
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23635
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
CY2017Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
93750
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-187438
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-188972
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22693
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26997
CY2018Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
195000
CY2017Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2152579
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1883975
CY2018Q1 us-gaap Revenues
Revenues
56590
CY2017Q1 us-gaap Stock Issued1
StockIssued1
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
698927
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
470795
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
780093
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
470795
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33243580
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22277261

Files In Submission

Name View Source Status
0001014763-18-000010-index-headers.html Edgar Link pending
0001014763-18-000010-index.html Edgar Link pending
0001014763-18-000010.txt Edgar Link pending
0001014763-18-000010-xbrl.zip Edgar Link pending
amar-20180331.xml Edgar Link completed
amar-20180331.xsd Edgar Link pending
amar-20180331_cal.xml Edgar Link unprocessable
amar-20180331_def.xml Edgar Link unprocessable
amar-20180331_lab.xml Edgar Link unprocessable
amar-20180331_pre.xml Edgar Link unprocessable
exhibit31-1a_03312018.htm Edgar Link pending
exhibit31-1b_03312018.htm Edgar Link pending
exhibit32-1_03312018.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q_03312018.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending